Syracuse, NY5 Active Studies

ADHD Clinical Trials in Syracuse, NY

Find 5 actively recruiting adhd clinical trials in Syracuse, NY. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
381
Enrolling

Recruiting ADHD Studies in Syracuse

NCT07309445Recruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

The purpose of this study is to assess how well TAR-200 works in real-word by measuring the time taken from the first TAR-200 insertion to worsening of cancer or until the signs and symptoms of cancer...

Syracuse, NY150 participantsJanssen Research & Development, LLC
View Study Details
NCT03945162Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

This is a phase II, open-label, single-arm, multi-center Study conducted in Canada and the United States. Patients with NMIBC CIS (with or without resected papillary disease (Ta, T1)) that are conside...

Syracuse, NYPHASE290 participantsTheralase® Technologies Inc.
View Study Details
NCT05491525Recruiting

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

The purpose of this study is to evaluate the safety, efficacy, and PK of vibegron in pediatric participants with NDO who are regularly using CIC...

Syracuse, NYPHASE271 participantsUrovant Sciences GmbH
View Study Details
NCT06800963Recruiting

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

This is a phase 1/2, open-label, multicenter study of intravesical Recombinant Mycobacterium Bacillus Calmette-Guérin (BCG) in participants with Non-muscle invasive bladder cancer (NMIBC) who have not...

Syracuse, NYPHASE140 participantsImmunityBio, Inc.
View Study Details
NCT07725796Recruiting

A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

This study is being conducted to evaluate the safety and tolerability of UGN-501 administered intravesically in adult participants with recurrent non-muscle invasive bladder cancer (NMIBC) and to dete...

Syracuse, NYPHASE130 participantsUroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
View Study Details

About ADHD Clinical Trials in Syracuse

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.

There are currently 5 adhd clinical trials recruiting participants in Syracuse, NY. These studies are seeking a combined 381 participants. Research is being sponsored by Janssen Research & Development, LLC, Theralase® Technologies Inc., Urovant Sciences GmbH and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

ADHD Clinical Trials in Syracuse — FAQ

Are there adhd clinical trials in Syracuse?

Yes, there are 5 adhd clinical trials currently recruiting in Syracuse, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Syracuse?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Syracuse research site will contact you about next steps.

Are clinical trials in Syracuse free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Syracuse studies also compensate for your time and travel.

What adhd treatments are being tested?

The 5 active trials in Syracuse are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.

Data updated October 21, 2026 from ClinicalTrials.gov